Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.



Quick Links

Veterans Crisis Line Badge
My healthevet badge

PRIME Care Study

  Prime Care Logo  

WEBINAR: Pharmacogenetics Trial of Depression: A Focus on Suicidal Thoughts
This VA Health Services Research & Development presentation led by PRIME Care principal investigator and VISN 4 MIRECC director David Oslin, M.D. provides an overview of the PRIME Care study including aims and progress to date and explains the research team's process for addressing suicidal ideation, rates of suicidal ideation and time-dependent changes in suicidal thoughts. Intended Audience: Research community. September 21, 2020

WEBINAR: Precision Medicine in Mental Health Care: Can Pharmacogenomic Testing Improve Antidepressant Outcomes?
This presentation led by Michael Thase, M.D. of the VISN 4 MIRECC reviews the current gaps in antidepressant prescribing and examines whether systematic use of pharmacogenomic testing can improve treatment outcomes. If you would like to view a full recording of this March 2019 presentation, email our team. Please note that Continuing Education credits are not available when viewing the recording.

WEBINAR: Precision Medicine in Mental Health Care: Incorporating Implementation Science into a Large-Scale RCT
This VA Health Services Research & Development Spotlight on Mental Health Centers of Excellence presentation led by PRIME Care principal investgator and VISN 4 MIRECC director David Oslin, M.D. and Center for Integrated Healthcare director Laura Wray, Ph.D., summarizes how the PRIME Care project incorporates implementation science methodology to support the trial and prepare for rapid implementation if the intervention proves to be effective. Intended Audience: anyone interested in how VA is evaluating and preparing for future use of PGx, including researchers, providers, and policy makers. December 10, 2018
VIDEO: Introduction to Pharmacogenetics: PRIME Care Study:
This whiteboard video briefly explains pharmacogenetics, what it is, and how it is being used in health care today. The role of pharmacogenetics in the VA PRIME Care study is described.
Running time: 2:59
Intended Audience: Patients and Providers

VIDEO: Welcome to PRIME Care!
This video provides an overview of the Precision Medicine in Mental Health Care (PRIME Care) study.
Running time: 2:17
Intended Audience: Patients

VIDEO: PRIME Care Study Introduction:
This video summarizes the VA PRIME Care study, including public health significance, study design, the pharmacogenetic test used, study hypotheses, and future directions.  
Running time: 21:59
Intended Audience: Providers

VIDEO: Introduction to Pharmacogenetic Testing for Providers:
This video provides an introduction to pharmacogenetics and discusses the potential application of pharmacogenetics to the mental health field. An overview of the VA PRIME Care study is presented.
Running time: 5:42
Intended Audience: Providers

VIDEO: Using Your Patient Test Results:
Utilizing four case examples, this video walks through the application of pharmacogenetic test results used in the VA PRIME Care Study.
Running time: 14:47
Intended Audience: Providers

VIDEO: Talking to Your Patients About Test Results:
Through the use of vignettes, this video provides guidance to providers on how to talk to their patients about the pharmacogenetic test used in the VA PRIME Care study and approaches for reviewing the results.
Running time: 15:01
Intended Audience: Providers ID: NCT03170362